Advertisement

Month: February 2019

Mylan launches Advair generic at one-third price

(Reuters) – Mylan NV on Tuesday priced its generic version of GlaxoSmithKline’s blockbuster asthma treatment Advair 70 percent lower than the branded medicine. The treatment, the first generic of Advair, is approved...

Read More

For latest news and updates
Email-id is invalid